(Q34837281)

4 August 2017

1 reference

title

COX-2 - a target for preventing hepatic carcinoma? (English)

1 reference

4 August 2017

Mohammad A Rahman

1

1 reference

4 August 2017

Hitoshi Kohno

series ordinal

2

1 reference

4 August 2017

Naofumi Nagasue

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Expert Opinion on Therapeutic Targets

4 August 2017

published in

1 reference

4 August 2017

volume

6

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

483-490

1 reference

Hepatocellular carcinoma: an update

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Regulation of cyclooxygenase-2 expression by nitric oxide in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Why is Hu where? Shuttling of early-response-gene messenger RNA subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1-expressing hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Review article: cyclooxygenase--a target for colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

The contributions of cyclooxygenase-2 to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.483

21 January 2018

Identifiers

DOI

10.1517/14728222.6.4.483

1 reference

4 August 2017

1 reference